Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Tata India Pharma & Healthcare Fund-Regular Plan-Growth - Portfolio Analysis

Portfolio Overview

Asset Allocation

Equity: 93.78%Others: 6.22%

Market Cap

Large Cap: 27.92%Mid Cap: 32.96%Small Cap: 30.52%Equity: 2.38%

Number of stocks

43

Top 10 Holdings

104.64% of portfolio

Market Cap of Equity

Large Cap
27.92%
Mid Cap
32.96%
Small Cap
30.52%
Equity
2.38%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd21.83%
Cipla Ltd13.23%
Apollo Hospitals Enterprise Ltd10.40%
Lupin Ltd9.53%
HealthCare Global Enterprises Ltd8.76%
Torrent Pharmaceuticals Ltd8.65%
Aster DM Healthcare Ltd Ordinary Shares8.65%
Fortis Healthcare Ltd8.00%
Alkem Laboratories Ltd8.00%
Max Healthcare Institute Ltd Ordinary Shares7.59%

Sector Allocation of Equity

Healthcare91.69%
Financial Services1.63%
Basic Materials0.46%

SIP Amount

Monthly SIP Date

Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.